Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerve Blocks vs Botox for Chronic Migraine
NCT06684249Recruiting
- Sponsor
- Zagazig University
- Start
- Nov 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, open-label trial of corticosteroids in chronic migraine (2 arms), sponsored by Zagazig University. Primary endpoint: Reduction in Monthly Migraine Days at 6 months. Started Nov 2024; status: recruiting.
02
Drugs
corticosteroids
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT06684249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06684249.